Does SARGRAMOSTIM Cause Neoplasm malignant? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neoplasm malignant have been filed in association with SARGRAMOSTIM (Leukine). This represents 0.8% of all adverse event reports for SARGRAMOSTIM.
5
Reports of Neoplasm malignant with SARGRAMOSTIM
0.8%
of all SARGRAMOSTIM reports
1
Deaths
4
Hospitalizations
How Dangerous Is Neoplasm malignant From SARGRAMOSTIM?
Of the 5 reports, 1 (20.0%) resulted in death, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SARGRAMOSTIM. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does SARGRAMOSTIM Cause?
Off label use (98)
Pyrexia (76)
Pain (56)
Hospitalisation (31)
Death (30)
Hypotension (25)
Device related infection (23)
Cough (20)
Febrile neutropenia (20)
Disease progression (18)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which SARGRAMOSTIM Alternatives Have Lower Neoplasm malignant Risk?
SARGRAMOSTIM vs SARILUMAB
SARGRAMOSTIM vs SATRALIZUMAB
SARGRAMOSTIM vs SATRALIZUMAB-MWGE
SARGRAMOSTIM vs SAXAGLIPTIN
SARGRAMOSTIM vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER